Advanced Urothelial Carcinoma clinical trials

Explore recruiting advanced urothelial carcinoma clinical trials.

Recruiting advanced urothelial carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Urothelial Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study

Austria

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1/2 Randomized, Umbrella Study to Evaluate the Efficacy and Safety of MK-2870 Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab, as Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04C

France, Spain, Denmark, Netherlands, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2, Umbrella Study of the Efficacy and Safety of Pembrolizumab plus Enfortumab vedotin +/- Investigational Agents in First-Line metastatic urothelial carcinoma

Netherlands, Spain, Italy, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Multicenter, Open-label Phase 1/2 Study of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF-301)

Spain, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma: A single-arm Phase 2 trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Urothelial Carcinoma trials by city

Advanced Urothelial Carcinoma in Toronto Advanced Urothelial Carcinoma in Vancouver Advanced Urothelial Carcinoma in Montreal Advanced Urothelial Carcinoma in Calgary Advanced Urothelial Carcinoma in Edmonton Advanced Urothelial Carcinoma in Ottawa Advanced Urothelial Carcinoma in Winnipeg Advanced Urothelial Carcinoma in Quebec City Advanced Urothelial Carcinoma in Hamilton Advanced Urothelial Carcinoma in Kitchener Advanced Urothelial Carcinoma in London Advanced Urothelial Carcinoma in Halifax Advanced Urothelial Carcinoma in New York Advanced Urothelial Carcinoma in Los Angeles Advanced Urothelial Carcinoma in Chicago Advanced Urothelial Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease